Studies of tumor cells and T lymphocytes have shown that heparanase expression can be induced by the transcription factor early growth response 1 (EGR1) which, itself, is dependent on ERK1/2 activity [49], [50]. This evidence concerns the gene MAPK3 and neoplasm.